Please ensure Javascript is enabled for purposes of website accessibility
Now accepting applications for SPARK™ - Albireo’s Grants in Rare Liver Disease program. Learn more.

Bile Acid Modulation

Albireo is the leader in bile acid science and is leveraging its expertise in bile acid modulation to bring novel, potentially transformative medicines to patients.

Based on mechanism of action and over a decade of gold standard R&D, we believe bile acid modulation with IBAT inhibition and other novel mechnanisms may benefit people with a wide range of cholestatic liver diseases.

Bile Acid Modulation

Albireo is the leader in bile acid science and is leveraging its expertise in bile acid modulation to bring novel, potentially transformative medicines to patients.

Based on mechanism of action and over a decade of gold standard R&D, we believe bile acid modulation with IBAT inhibition and other novel mechnanisms may benefit people with a wide range of cholestatic liver diseases.

About Us

We are relentlessly focused on bringing new medicines to patients.

Lorem

Financial Overview

Title

Status: Recruiting
Description

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.

Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipiscing elit nunc cursus velit elit. Sed dictum lacus consequat vitae. sed dictum lacus consequat vitae ipsum dolor sit amet.

First Name Last Name

First Name Last Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit nunc cursus velit elit. Sed dictum lacus consequat vitae. sed dictum lacus consequat vitae ipsum dolor sit amet.

First Name Last Name

Join Our Team

If you are an exceptional teammate driven by a commitment to helping patients, Albireo is the right place for you.

View Open Positions
Science & Medicine

Programs & Treatments

About Us

Our People

Partnerships

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Learn More

Board of Directors

  • Michael
    Gutch, Ph.D.
    Chief Business Officer & Chief Financial Officer, Entasis Therapeutics
  • Michael
    Gutch, Ph.D.
    Chief Business Officer & Chief Financial Officer, Entasis Therapeutics
  • Michael
    Gutch, Ph.D.
    Chief Business Officer & Chief Financial Officer, Entasis Therapeutics
  • Michael
    Gutch, Ph.D.
    Chief Business Officer & Chief Financial Officer, Entasis Therapeutics
  • Michael
    Gutch, Ph.D.
    Chief Business Officer & Chief Financial Officer, Entasis Therapeutics
  • Michael
    Gutch, Ph.D.
    Chief Business Officer & Chief Financial Officer, Entasis Therapeutics

Bylvay (Odevixibat)

Bylvay is the first drug approved for the treatment of pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), a spectrum of life-threatening, rare, pediatric liver diseases.

Odevixibat

Odevixibat is a potent, non-systemic ileal bile acid transport inhibitor (IBATi). Albireo is developing odevixibat to treat rare pediatric cholestatic liver diseases.

Odevixibat

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Email Alerts

Lorem ipsum dolor sit amet, consectetur adipisicing elit.

Sign Up
  • Name
  • Indication
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Approved
BylvayTM (Odevixibat)
PFIC
Description

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.

Billiary Atresia
Description

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.


A3907
Adult Liver Diseases
Description

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.


A3907
Adult Liver Diseases
Description

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.


A3907
Adult Liver Diseases
Description

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.


Bile Acid Modulators
Undisclosed
Description

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate.